Teva Pharmaceutical Industries (TEVA) Cash from Operations (QoQ) (2009 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) Cash from Operations (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.57 Bn | 38.91 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 406.25 Mn | 365.00 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,127.50% |
| Mar 31, 2026 | -103.45% |
| Dec 31, 2025 | 213.82% |
| Sep 30, 2025 | 62.56% |
| Jun 30, 2025 | 316.19% |
| Mar 31, 2025 | -118.26% |
| Dec 31, 2024 | -17.03% |
| Sep 30, 2024 | 572.82% |
| Jun 30, 2024 | 183.06% |
| Mar 31, 2024 | -110.47% |
| Dec 31, 2023 | 23,580.00% |
| Sep 30, 2023 | -98.46% |
| Jun 30, 2023 | 323.45% |
| Mar 31, 2023 | -114.90% |
| Dec 31, 2022 | 79.19% |
| Sep 30, 2022 | 341.46% |
| Jun 30, 2022 | 351.02% |
| Mar 31, 2022 | -110.75% |
| Dec 31, 2021 | -13.80% |
| Sep 30, 2021 | 142.66% |